Karl Eckert
Impact in
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
- Virus-based gene therapy research
- Developmental Neuroscience top 5%
- Neurogenesis and neuroplasticity mechanisms
Papers in
- Genetics 14
- Chronic Lymphocytic Leukemia Research 14
-
- Lymphoma Diagnosis and Treatment 7
- Cancer Mechanisms and Therapy 2
- Co-authors
- Richard E. Sutton (1 shared paper)Irving L. Weissman (1 shared paper)Brent T. Harris (1 shared paper)Michael J. Reitsma (1 shared paper)Leo W.K. Cheung (5 shared papers)Sunil Jain (1 shared paper)Fred H. Gage (1 shared paper)Robert J. Tushinski (1 shared paper)
- Journals
- Blood (5 papers)British Journal of Haematology (3 papers)Journal of Virology (1 paper)Sustainability (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesAustraliaBelgium
In The Last Decade
Karl Eckert
20 papers receiving 685 citations
Peers
Comparison fields: 5 of 71
- Genetics 345
- Developmental Neuroscience 104
- Pathology and Forensic Medicine 310
- Oncology 164
- Hematology 63
Countries citing papers authored by Karl Eckert
This map shows the geographic impact of Karl Eckert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl Eckert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl Eckert more than expected).
Fields of papers citing papers by Karl Eckert
This network shows the impact of papers produced by Karl Eckert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl Eckert. The network helps show where Karl Eckert may publish in the future.
Co-authors
The 25 scholars most cited alongside Karl Eckert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 208 | |
| 2 | 2001 | 70 | |
| 3 | 2017 | 56 | |
| 4 | 2015 | 49 | |
| 5 | The role of PIM1 in the ibrutinib-resistant ABC subtype of diffuse large B-cell lymphoma. | 2016 | 49 |
| 6 | 2021 | 43 | |
| 7 | 2019 | 38 | |
| 8 | 2018 | 36 | |
| 9 | 2018 | 33 | |
| 10 | 2023 | 33 | |
| 11 | 2020 | 24 | |
| 12 | 2014 | 15 | |
| 13 | 2022 | 13 | |
| 14 | 2022 | 9 | |
| 15 | 2014 | 9 | |
| 16 | 2015 | 8 | |
| 17 | 2020 | 5 | |
| 18 | 2022 | 3 | |
| 19 | 2009 | 2 | |
| 20 | Haematologic and immunologic function and patient-reported outcomes for the phase 3 RESONATE (TM) study of ibrutinib versus ofatumumab in relapsed/refractory chronic lymphocytic leukaemia/small lymphocytic lymphoma | 2015 | 1 |
About Karl Eckert
Karl Eckert is a scholar working on Genetics, Pathology and Forensic Medicine, Immunology, Hematology and Developmental Neuroscience, having authored 21 papers that have together received 704 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (14 papers), Lymphoma Diagnosis and Treatment (7 papers), Immunodeficiency and Autoimmune Disorders (3 papers), Cancer Mechanisms and Therapy (2 papers), Chronic Myeloid Leukemia Treatments (2 papers), Galectins and Cancer Biology (2 papers), Viral-associated cancers and disorders (2 papers) and Viral gastroenteritis research and epidemiology (1 paper). The work is most often cited by research in Genetics (345 citations), Developmental Neuroscience (104 citations), Pathology and Forensic Medicine (310 citations), Oncology (164 citations) and Hematology (63 citations). Karl Eckert has collaborated with scholars based in United States, Australia and Belgium. Frequent co-authors include Richard E. Sutton, Irving L. Weissman, Brent T. Harris, Michael J. Reitsma, Leo W.K. Cheung, Sunil Jain, Fred H. Gage, Robert J. Tushinski, Ann S. Tsukamoto and Dongping He. Their work appears in journals such as Blood, British Journal of Haematology, Journal of Virology, Sustainability and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.